Substance use in a population-based clinic sample of people with first-episode psychosis
about
The genetics of bipolar disorderPsychosocial interventions for cannabis abuse and/or dependence among persons with co-occurring cannabis use and psychotic disordersQ24197685Epigenetic mediation of environmental influences in major psychotic disordersSubstance dependence: Decades apart in a teaching hospitalSubstance use in clinical high risk for psychosis: a review of the literatureIncidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analysesAn intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?Genome-wide association study in bipolar patients stratified by co-morbiditySearching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosisMorphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illnessAre cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Striatal dopamine release in schizophrenia comorbid with substance dependence.Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.Severe and enduring mental health problems within an established substance misuse treatment partnership.Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studiesDaily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.Dual diagnosis, as described by those who experience the disorder: using the Internet as a source of data.Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment areaDrug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosisRisk and protective factors associated with substance use disorders in adolescents with first-episode maniaSubstance use in people at clinical high-risk for psychosis.Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.Diagnostic change 10 years after a first episode of psychosisAssociation between age at onset of psychosis and age at onset of cannabis use in non-affective psychosisEnvironmental Risk and Protective Factors and Their Influence on the Emergence of PsychosisSubstance use disorder among people with first-episode psychosis: a systematic review of course and treatment.Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend.Cannabis withdrawal in chronic cannabis users with schizophreniaAssociation of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational studyCannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study
P2860
Q22251249-4C628798-AAEE-4A55-B052-D026E4A50A8FQ24186871-526DAE93-7F18-4E47-94B2-5A8A1D253A61Q24197685-8CBCE620-AD20-4F94-AA1E-47026414984EQ24652697-17E2E6EF-EDE1-4A71-A7FB-C1EFCE595313Q24658425-F9D5F3C0-0F9B-44BA-8C59-8AE3879177E5Q26859349-DD8FFCB2-49BE-4A1A-95B7-B57B1B31F699Q27000464-DE981622-ADA9-4104-9A12-1F5CA104E2A9Q27491346-D345100A-EC85-4C5C-BAA8-2458C33E4527Q28741033-4517565E-0BE8-4D0E-9A08-1143C1F181CEQ30375488-E857F405-8E47-4956-B06B-BECA21FE68DBQ30467190-F7253C27-39E5-49A1-817D-7B8ECEDD8F16Q33664684-0C84CA47-0BD1-44F7-B7AE-DC3525F00260Q33849637-5962B6C3-8EC1-450C-8CC6-4414DA3D4651Q33950987-95F6A9DE-EDD8-4FAC-B73C-6657F279F819Q33976751-9D5CC39B-F723-46EF-B826-E2789E928A95Q34028727-FD8BC8FF-026C-4C0C-A55A-6F6737E4CACDQ34235419-F595DD41-AF0C-4F3F-8195-6793CC9ECB70Q34271409-B1E06946-35BC-4C39-AE1C-D30767E00AF7Q34282907-AB27BCA9-F59D-4786-B943-CF2E42B4F762Q34322915-9BFA1B66-0314-41E9-AD9E-6E82CE50141EQ34351360-CA4FFEDD-AF45-4328-89E6-35C563D0F7A8Q34464734-A769625B-083E-43A5-9864-B1BF424C201FQ34509725-DD0D858F-1582-4FA0-B519-9BF2931BB6ECQ34556368-95A34C58-9A38-4D2E-91D2-EA6F41DB3C09Q34569376-85EC5331-6783-41BF-905C-4468745692E7Q34612418-21D997CF-B3D9-4E3D-8503-497C8B98ACCBQ34644737-4EB63BD3-ADC0-44C1-9B2F-AAD6C8DDDCD9Q34889141-39FAE382-CE51-4ABC-AA39-68FD2DD70C92Q34987780-E1C4C72F-A797-40D1-9E1D-F8CBE9A5A23CQ35046489-3413FD27-D798-4277-8A20-93ECD321196EQ35136787-1B9F1218-093A-404D-9F3F-D40A22D4CA79Q36121507-7668BF9F-32BE-47D7-BF8B-94DC55C6B9C7Q36129243-AA63C46D-C797-474D-9F34-C575CB778067Q36154276-E0E67DC7-F504-4C0E-A469-A0AE5FEF6E0BQ36367296-0D2B8337-4E49-42F9-95C1-050B60BB8CB4Q36618852-E4A9A483-6798-44A7-8A2D-1D73AF676BCCQ36620997-558BC66F-B91D-4EFD-AE49-2FDBDA7CD956Q36666842-FD91F77F-6EB3-4A7A-B9F5-7DA9D90DC88CQ36670457-EF375C64-C749-427F-89F9-3C749515004DQ36817167-55843311-3EAE-4019-AD72-4433A6DFCFD4
P2860
Substance use in a population-based clinic sample of people with first-episode psychosis
description
article
@en
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2007
@uk
name
Substance use in a population-based clinic sample of people with first-episode psychosis
@en
Substance use in a population-based clinic sample of people with first-episode psychosis
@nl
type
label
Substance use in a population-based clinic sample of people with first-episode psychosis
@en
Substance use in a population-based clinic sample of people with first-episode psychosis
@nl
prefLabel
Substance use in a population-based clinic sample of people with first-episode psychosis
@en
Substance use in a population-based clinic sample of people with first-episode psychosis
@nl
P2093
P50
P1476
Substance use in a population-based clinic sample of people with first-episode psychosis
@en
P2093
David E Pernet
Jennifer H Barnett
Katherine E Hill
Kim Masson
Rossa Brazil
Sandra M Secher
Ursula Werners
P304
P356
10.1192/BJP.BP.106.024448
P407
P577
2007-06-01T00:00:00Z